As U.S. politicians including presidential candidates Hillary Clinton and Donald Trump shower criticism on the pharmaceutical industry, drugmakers need to change their tune, Regeneron Pharmaceuticals Inc. Chief Executive Officer Len Schleifer said.
“We are going to have to do a better job at explaining the value proposition of products we bring out,” Schleifer said Wednesday at a Bloomberg pharma event in New York. “We need to be reasonable about the way we price these things.”
